Lung cancer is far and away the leading cause of cancer deaths worldwide. In the U.S. alone, a projected 142,000 people will die of the disease this year.
It is hard to get much of a reputation if nobody knows you’re around, and that has definitely been the case for mycoplasma genitalium, the tiny bacteria estimated to be more prevalent than the bug that causes gonorrhea but is almost completely off the public’s radar.
That’s because, until very recently, it has been difficult for front-line physicians to confirm that this particular microbe — the smallest bacteria ever detected — was present in specific patients.
In an open-label study of women in southern and eastern Africa, a vaginal ring that is inserted once a month and slowly releases an antiviral drug was estimated to reduce the risk of HIV by 39%, according to statistical modeling. In addition, the study found that participants appeared to use the ring more in the open-label study than in a previous clinical trial. These and other results of the HIV Open Label Extension (HOPE) study were presented today at the 10th IAS Conference on HIV Science (IAS 2019) in Mexico City.
Jay Inslee, the governor of Washington state, has said climate change is the “driving motivation” for his presidential campaign; some of his opponents agree, particularly after an April CNN/SSRS poll found that 82 percent of Democrats and Democratic-leaning voters described the issue as “very important.” One of these candidates will face off in the general election against a president who ran on the assurance that “I believe in clean air. Immaculate air.
Seven University of Washington faculty members recently joined more than 200 researchers from 40 different countries in a call to action to protect the independence and integrity of global health research. The editorial, published in the most recent issue of BMJ Global Health, highlights the pervasiveness of donor and NGO influence on program evaluation findings and dissemination.
In high-income countries like the U.S., the standard of care for people infected by HIV is to provide antiretroviral pills when the virus is found, even when there are no symptoms of AIDS. The strategy staves off the disease and has a second – big – benefit. It's been shown to prevent the spread of HIV in sexual encounters. It's called "treatment as prevention" (TasP in medical jargon), or "test and treat."
But in low-income countries, "test and treat" is not the typical approach to prevention. There's been no research to support it.
By Donald G. McNeil Jr., The New York Times
The hormone shot — popular among African women who must use birth control in secret — is as safe as other methods, scientists reported.
For decades, many African women in need of birth control they could use in secret have relied on intramuscular hormone injections that prevent pregnancy for three months.
The global health community needs the humility to acknowledge that we have failed once again in an Ebola epidemic, say Karin Huster and Justin Healy
New research is shedding light on the correlations between climate change, social instability, and health.
Fast Company - We know that rising carbon dioxide levels in the atmosphere are raising global temperatures and creating unstable and extreme weather patterns that will continue to threaten communities across the globe.